Tuberculosis treatment study in France
Part of Infections clinical trials.
This study follows people starting treatment for tuberculosis (TB) in France to learn more about the disease and its treatment. If you have been diagnosed with TB and started treatment within the last 8 days, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with tuberculosis (TB) through lab tests or by a doctor.
- You started TB treatment less than 8 days ago.
- You are willing to give written consent to join the study. If you have TB meningitis or a severe form that affects your mind, a family member can give consent for you.
- You do not have severe memory or thinking problems that would make it hard to give consent (unless you have TB meningitis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding dedicated nursing support in and out of the hospital helps people with tuberculosis complete their treatment and recover better.
This study tests new, faster ways to diagnose tuberculosis (TB) using samples like sputum (mucus from your lungs), tongue swabs, and urine. It aims to see if these new tests can find TB more accurately than current methods, which could help you get the right treatment sooner.
This study is a registry that collects information from adults with tuberculosis in Europe. It helps researchers better understand the disease and improve care.
This trial tests a shorter treatment regimen for people with tuberculosis (TB) who don't have symptoms. If you have TB bacteria in your lungs but no cough, fever, night sweats, or weight loss, this study may offer a more convenient treatment option.
This study is testing a new blood test (IGRA) to see if it can help doctors diagnose active and latent (hidden) tuberculosis. If you are already being treated for TB and have had an IGRA blood test, you may be able to join.
This study follows people with suspected or confirmed tuberculosis (TB), whether they have inactive “latent” TB or active TB. It helps researchers better understand TB’s natural course and may improve future testing and care by allowing collection and storage of samples.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.